We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lab-on-a-Chip Measures Mechanics of Bacteria Colonies

By LabMedica International staff writers
Posted on 06 Jul 2009
A microfluidic device, also known as a lab-on-a-chip, estimates biofilms resistance to pressure. More...
Biofilms experience various kinds of pressure in nature and in the body as they squeeze through capillaries and adhere to the surfaces of e.g., medical devices.

Most bacteria in nature form biofilms. Bacteria are single-celled organisms, but they rarely live alone, said John Younger, associate chair for research in the department of emergency medicine at the University of (U-M) Health System (UHMS; Ann Arbor, MI, USA). Prof. Younger is a coauthor of the study that forms the cover story of the July 7, 2009 edition of Langmuir.

To understand biofilms and their life cycle, it is necessary to consider their genetics as well as their mechanical properties. Biofilms are "materials that respond to forces, because how they live in the environment depends on that response," said Mike Solomon, associate professor of chemical engineering and macromolecular science and engineering, who is senior author of the paper.

The U-M microfluidic device provides the right scale. The channel-etched chip, made from a flexible polymer, allows scientists to study minute samples of between 50 and 500 bacterial cells that form biofilms of 10-50µ in size. Such small samples behave in the device as they do in the body. Tools that require larger samples do not always give an accurate picture of how a particular substance behaves on the smallest scales.

The biofilms studied had a greater elasticity than previous methods had measured. The scientists discovered a hardening response, which means that the more pressure applied to the biofilms, the more resistance the materials put forth.

Mechanical forces are set in motion when we defend ourselves against these bacterial colonies. Gene expression patterns can be studied indefinitely, but until it is known when the materials will bend or break and what the immune system has to do from a physical perspective, how to fight this opponent remains a mystery.

Experiments were performed on colonies of Staphylococcus epidermidis and Klebsiella pneumoniae, which are known to cause infections in hospitals. The new microfluidic device could also be used to measure the resistance of various other soft-solid materials in biomaterials, pharmaceutical fields, consumer products, and food science.

Related Links:
Department of Emergency Medicine at the University of Michigan Health System




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.